Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Expert Rev Proteomics ; 11(3): 395-404, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24684205

ABSTRACT

UNLABELLED: Cerebral cavernous malformations (CCM) are vascular anomalies caused by mutations in genes encoding KRIT1, OSM and PDCD10 proteins causing hemorrhagic stroke. We examine proteomic change of loss of CCM gene expression. Using human umbilical vein endothelial cells, label-free differential protein expression analysis with multidimensional liquid chromatography/tandem mass spectrometry was applied to three CCM protein knockdown cell lines and two control cell lines: ProteomeXchange identifier PXD000362. Principle component and cluster analyses were used to examine the differentially expressed proteins associated with CCM. The results from the five cell lines revealed 290 and 192 differentially expressed proteins (p < 0.005 and p < 0.001, respectively). Most commonly affected proteins were cytoskeleton-associated proteins, in particular myosin-9. Canonical genetic pathway analysis suggests that CCM may be a result of defective cell-cell interaction through dysregulation of cytoskeletal associated proteins. CONCLUSION: The work explores signaling pathways that may elucidate early detection and novel therapy for CCM.


Subject(s)
Hemangioma, Cavernous, Central Nervous System/chemistry , Proteome/analysis , Systems Biology , Cell Line , Cytoskeleton/metabolism , Gene Expression Profiling , Hemangioma, Cavernous, Central Nervous System/metabolism , Humans , Signal Transduction
2.
Mol Biosyst ; 10(7): 1881-9, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24770493

ABSTRACT

Three genetic mutations were found to cause cerebral cavernous malformation (CCM), a vascular anomaly predisposing affected individuals to hemorrhagic stroke. These CCM proteins function together as a protein complex in the cell. Loss of expression of each CCM gene results in loss of in vitro endothelial tube formation. Label-free differential protein expression analysis using multidimensional liquid chromatography/tandem mass spectrometry (2D-LC-MS/MS) was applied to explore the proteomic profile for loss of each CCM gene expression in mouse endothelial stem cells (MEES) compared to mock shRNA and no shRNA control cell-lines. Differentially expressed proteins were identified (p < 0.05). 120 proteins were differentially expressed among the cell-lines. Principal component analysis and cluster analysis show the effects of individual knockdown. In all knockdown cell-lines, altered expression of cytoskeletal proteins is the most common. While all CCM mutations result in similar pathology, different CCM mutations have their own distinct pathogenesis in cell signaling.


Subject(s)
Cytoskeletal Proteins/genetics , Cytoskeletal Proteins/metabolism , Hemangioma, Cavernous, Central Nervous System/pathology , Proteomics/methods , Signal Transduction , Animals , Cell Line , Chromatography, Liquid , Cluster Analysis , Endothelial Cells/pathology , Endothelial Cells/physiology , Gene Expression Regulation , Gene Knockdown Techniques , Hemangioma, Cavernous, Central Nervous System/genetics , Humans , Mice , Principal Component Analysis , Tandem Mass Spectrometry
SELECTION OF CITATIONS
SEARCH DETAIL
...